Important note: Information in this article was accurate in 1997. The state of the art may have changed since the publication date.
PR Newswire, 810 Seventh Avenue, New York, NY 10019 - Monday September 29 10:28 AM EDT
Following the release of adult treatment guidelines, the National Institute of Child Health and Human Development, the National Pediatric and Family HIV Resource Center and the Health Resources and Service Administration reconvened a Working Group on Antiretroviral Therapy of Children with HIV to provide pediatric guidelines in concert with recommendations for adults. Pediatric AIDS Foundation Scientific Director, Cathy Wilfert participated in formulating these guidelines and urged for both the adult and pediatric guidelines to be published simultaneously.
Due to the lack of trial data in young children, the pediatric guidelines include notes of caution when administering protease inhibitors to patients, unlike the guidelines for adults which are based on more extensive clinical testing. Protease inhibitors were only approved for use in children ages 2-12 last March. There still isn't a protease inhibitor for use in children under the age of 2.
"We are glad that these guidelines provide the tools that are urgently needed to bring kids into modern therapy," said Susan DeLaurentis, co-founder of the Pediatric AIDS Foundation. "This disease works faster and is more deadly in children than adults and we look forward to seeing updated, more aggressive guidelines."
The White House has proposed a new FDA regulation requiring pharmaceutical companies to conduct pediatric and adult trials simultaneously for new drugs. This regulation will eliminate the current discrepancy between the treatment of adults and children infected with HIV.
The Pediatric AIDS Foundation is the leading national non-profit organization dedicated to identifying, funding and conducting basic pediatric AIDS research. The Foundation's goals include reducing transmission from an HIV-infected mother to her newborn, prolonging and improving the lives of children living with HIV, eliminating HIV in infected children and promoting awareness and compassion about HIV/AIDS.
SOURCE Pediatric AIDS Foundation
Copyright (c) 1997/PR NewsWire. Reproduced with permission. Reproduction of this article (other than one copy for personal reference) must be cleared through the Permissions Desk, PR Newswire, 810 Seventh Avenue, New York, NY 10019.
970929
PR970915
Copyright © 1997 - PRNewswire. All rights reserved. Reproduced with permission. Reproduction of this article (other than one copy for personal reference) must be cleared through PRNewswire, Permissions, 810 Seventh Ave., 32nd Floor, New York, NY 10019 http://www.prnewswire.com.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, National Library of Medicine, and donations from users like you.
Always watch for outdated information. This article first appeared in 1997. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 1997. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .